Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect

Survey of Ophthalmology

Volumn 41, Issue SUPPL. 2, 1997, Pages

  Bito, L Z ^a  

^a Columbia University ^*  (United States)

Author keywords

eye color; glaucoma drugs; intraocular pressure reduction; latanoprost; melanin; melanocytes; normal tension glaucoma; prostaglandins; uveoscleral outflow

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; LATANOPROST; MELANIN; MUSCARINIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROTRANSMITTER; PHXA85; PILOCARPINE; PRODRUG; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN F2 ALPHA; UNCLASSIFIED DRUG;

ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; CATARACTOGENESIS; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; CONJUNCTIVA DISEASE; CORNEA DISEASE; DRUG EFFICACY; DRUG POTENCY; EYE COLOR; GLAUCOMA; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MELANOGENESIS; NAUSEA; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SWEATING; TOPICAL DRUG ADMINISTRATION; VERTIGO;

EID: 0030946444     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0039-6257(97)80002-1     Document Type: Conference Paper

References (76)

1. 2α in ultraviolet radiation-induced cortical cataracts in vivo Invest Ophthalmol Vis Sci 37 1996 1539 1548
2. A Aim C Camras P Watson Phase 3 latanoprost studies: Masked 6-month comparisons with timolol, in the United Kingdom, Scandinavia and USA Surv Ophthahnol 41 Suppl 2 1997 S105 S110
3. N Bazan G Allan Signal transduction and gene expression in the eye: A contemporary view of the pro-inflainmatory, anti-inflammatory, and modulatory roles of prostaglandins and other bioactive lipids Surv Ophthalmol 41 Suppl 2 1997 S23 S34
4. B Becker Does hyposecretion of aqueous humor damage the trabecular meshwork? Glaucoma 4 1995 303 305
5. P Bhattacheljee The role of arachidonate metabolites in ocular inflammation Prog Clin Biol Res 312 1989 211 227
6. A Bill Uveoscleral drainage of aqueous humor: Physiology and Pharmacology Prog Clin Biol Res 312 1989 417 427
7. A Bill CI Philips Uveoscleral drainage of aqueous humor in human eyes Exp Eye Res 12 1971 275 281
8. LZ Bito Species differences in the responses of the eye to irritation and trauma: A hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research Exp Eye Res 39 1984 807 829
9. LZ Bito Prostaglandins: Old concepts and new perspectives Arch Ophthalmol 105 1987 1036 1039
10. LZ Bito A physiological approach to glaucoma management: The use of local hormones and the pharmacokinetics of prostaglandin esters Prog Clin Biol Res 312 1989 329 347
11. LZ Bito Glaucoma: Aphysiologic perspective with Darwinian overtones J Glaucoma 1 1992 193 205
12. LZ Bito Transport functions of the blood-ocular and bloodbrain barriers, and the microenvironment of neuronal and non-neuronal tissues MB Segal Barriers and Fluids of the Eye and Brain 1992 Macmillan Press London 14 23
13. LZ Bito hnpact of intraocular pressure on venous outflow from the globe: A hypothesis regarding IOP-dependent vascular damage in normal-tension and hypertensive glaucoma J Glaucoma 5 1996 127 134
14. Bito LZ: Physiological aspects of glaucoma and its management, in Zimmerman T, Kooner K, Sharir M (eds): Textbook of Ocular Pharmacology. New York, Raven Press (in press)
15. LZ Bito CB Camras GG Gum B Resul The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals Prog Clin Biol Res 312 1989 349 368
16. LZ Bito OC Miranda Accommodation and presbyopia RD Reinecke Ophthalmology Annual 1989 Raven Press New York 103 128
17. LZ Bito J Stjernschantz The ocular effects of prostaglandins and other eicosanoids 1989 Alan R. Liss New York
18. 2αanalog, PhXA41 (latanoprost), for glaucoma management J Lipid Med 6 1993 535 543
19. DC Broadway I Grierson C O'Brien RA Hitchings Adverse effects of topical antiglaucoma medication I. The conjunctival cell profile. Arch Ophthalmol 112 1994 1437 1445
20. RF Brubaker Fluorophotometric studies ofprostaglandin effects on the human eye: The lack of association of reduced intraocular pressure with altered flow or barrier function Prog Clin Biol Res 312 1989 477 481
21. RF Brubaker Flow of aqueous humor in humans Invest Ophthalmol Vis Sci 32 1991 3145 3166
22. CB Camras A Aim A review of available initial clinical reports on topically applied prostanoids Surv Ophthalmol 41 Suppl 2 1997 S61 S68
23. CB Camras LZ Bito KE Eakins Reduction of intraocular pressure by prostaglandin applied topically to the rabbit eye Invest Ophthalmol Vis Sci 16 1977 1125 1134
24. 2α or epinephrine on cynomolgus monkey eyes III. Histopathology. Invest Ophthalmol Vis Sci 29 1988 1428 1436
25. CB Camras O Miranda The putative role ofprostaglandins in surgical miosis Prog Clin Biol Res 312 1989 197 210
26. CB Camras GL Zhan YL Wang Effect ofsympathectomy (SX) and prostaglandin (PG) analog (latanoprost) treatment in pigmented rabbits (abstract) Invest Ophthalmol Vis Sci 36 Suppl 1995 S720
27. OB Carino AP Matheny CJ De Rousseau LZ Bito Changes in iridial pigmentation past childhood through adolescence (abstract) Invest Ophthalmol Vis Sci 35 Suppl 1994 15 30
28. Bito LZ, Matheny A, Cruickshanks KJ, et al: Eye color changes past early childhood: The Louisville Twin study. Arch Ophthalmol (in press)
29. LL DeSantis VL Sallee Comparison of the effects of prostaglandins and their esters on blood-aqueous barrier integrity and intraocular pressure in rabbits Prog Clin Biol Res 312 1989 379 386
30. J Dillon RH Wang S Atherton Photochemical and photophysical studies on human lens constituents Photochem Photobiol 52 1990 849 854
31. SM Drance Glaucoma — Changing concepts Eye 6 1992 337 345
32. RC Eagle Iris pigmentation and pigmented lesions: An ultrastructural study Trans Am Ophthahnol Soc 88 1988 581 687
33. KE Eakins Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier Exp Eye Res 25 1977 483 498
34. 2α in the human eye. Graefes Arch Clin Exp Ophthalmol 222 1985 139 141
35. E Greve A Rulo FPJ Hoyng SM Drance Reduction ofintraocular pressure in normal tension glaucoma with different therapeutic regimens of latanoprost: A review of shortterm studies with three dose regimens Surv Ophthalmol 41 Suppl 2 1997 S89 S92
36. SS Hayreh Progress in the understanding of the vascular etiology of glaucoma Curt Opin Ophthalmol 5 1994 26 35
37. J Hedner N Svedmyr H Lunde A Mandahl The lack of respiratory effects of the oculo hypotensive drug latanoprost in patients with moderate asthma Surv Ophthalmol 41 Suppl 2 1997 S11 l S115
38. FG Holz B Piguet DC Minassian Decreasing stromal iris pigmentation as a risk tactor for age-related inacular degeneration AmJ Ophthalmol 117 1994 19 23
39. PD Imesch IHL Wallow RA Spritz DM Albert The color of the human eye: A review of morphologic correlates and some conditions that affect iridial pigmentation Surv Ophthalmol 41 Suppl 2 1997 S117 S123
40. MA Kass A Neufeld ML Sears Systemic aspirin and indomethacin do not prevent the response of the monkey eye to trauma Invest Ophthahnol Vis Sci 14 1975 604 606
41. 2α lowers intraocular pressure Prog Clin Biol Res 312 1989 387 416
42. A Laties Ocular melanin and the adrenergic innervation to the eye Trans Am Ophthalmol Soc 72 1974 560 605
43. JD Lindsey K Kashiwagi E Kashiwagi RN Weinreb Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Applications for uveoscleral outflow Surv Ophthalmol 41 Suppl 2 1997 S53 S59
44. E Lutjen-Drecoll E Tamm Morphological study of the anterior segment ofcynomolgus monkey eyes following treatment with prostaglandin F2 Exp Eye Res 47 1988 761 769
45. 2α -isopropylester on anterior segment morphology. Prog Clin Biol Res 312 1989 437 446
46. J Masferrer P Kulkarni Cyclooxygenase-2 inhibitors: A new approach to the therapy of ocular inflammation Surv Ophthahnol 41 Suppl 2 1997 S35 S40
47. AP Matheny AB Dolan Changes in eye colour during early childhood: Sex and genetic differences Ann Hum Biol 2 1975 191 196
48. O Miranda LZ Bito The putative and demonstrated miotic effects of prostaglandins in mammals Prog Clin Biol Res 312 1989 171 195
49. OC Miranda LZ Bito H Kirby In vitro models for the study of some fundamental aspects of the ocular pharmacokinetics and pharmacodynamics of primary and derived prostaglandins (PGs) and their carboxylic acid esters (abstract) Invest Ophthalmol Vis Sci 28 Suppl 1987 11
50. HK Mishima Y Kiuchi M Takamatsu The effects of latanoprost on diurnal and nocturnal IOP and aqueous humor dynamics Surv Ophthahnol 41 Suppl 2 1997 S139 S144
51. L Misotten The UV scenario for senile cataract: Fact or fiction? Doc Ophthahnol 88 3-4 1995 195 349
52. AH Neufeld LM Jampol ML Sears Aspirin prevents the disruption of the blood-aqueous barrier of the rabbit eye Nature 238 1972 158 159
53. JJ Nordlund The pigmentary system: An expanded perspective Ann Dermatol 6 1994 109 123
54. DH Nugteren The determination ofprostaglandin inetabolites in human urine J Biol Chem 250 1975 2808 2812
55. JR Polansky RM Kurtz JA Alvarado Eicosanoid production and glucocorticoid regulatory mechanisms in cultured trabecular meshwork cells Prog Clin Biol Res 312 1989 113 138
56. JR Polansky IS Wood MT Maglio JA Alvarado Trabecular meshwork cell culture in glaucoma research: Evaluation of biological activity and structural properties of human trabecular cells in vitro Ophthalmology 91 1984 580 595
57. G Prota Melanin and Melanogenesis 1992 Academic Press San Diego
58. P Racz MR Ruzsonyi ZT Nagy Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol Arch Ophthalmol 114 1996 268 273
59. B Resul J Stjernschantz G Selen LZ Bito Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids Surv, Ophthalmol 41 Suppl 2 1997 S47 S52
60. B Samuelsson R Paolette Advances in Prostaglandin, Thromboxane, and Leukotriene Research 1976-1995 Raven Press New York Volumes 1-23
61. V Schuster Identification and characterization of a prostaglandin transporter widely expressed in ocular and other secretory epithelia Surv Ophthalmol 41 Suppl 2 1997 S41 S45
62. G Selen J Stjernschantz B Resul Prostaglandin-induced iridial pigmentation in primates Surv Ophthalmol 41 Suppl 2 1997 S125 S128
63. B Sjoquist P Byding B Result J Stjernschantz The systemic pharmacokinetics oflatanoprost in man after intravenous and topical administration (abstract) Invest Ophthalmol Vis Sci 35 Suppl 1994 2220
64. A Spector Oxidative stress-induced cataract mechanism of action FASEBJ 9 1995 1173 1182
65. J Stjernschantz Prostaglandins as ocular hypotensive agents: Development of an analogue for glaucoma treatment B Samuelsson Advances in Prostaglandin, Thromboxane and Leukotriene Research 1995 Raven Press, Ltd. New York 63 68
66. J Stjernschantz LZ Bito The ocular effects of eicosanoids and other autacoids: Historic background and the need for a broader perspective Prog Clin Biol Res 312 1989 1 13
67. J Stjernschantz G Selen B Sjoquist B Resul Preclinical pharmacology of latanoprost, a phenyl-substituted PGFz, analogue B Samuelsson Advances in Prostaglandin, Thromboxane and Leukotriene Research 1995 Raven Press, Ltd. New York 513 518
68. B Svedbergh I Forsberg A morphological study on the effects of chronic administration of latanoprost on the ciliary muscle and trabecular meshwork in monkeys (abstract) Invest Ophthalmol Vis Sci 34 Suppl 1993 932
69. 2α An uhrastructural study in rhesus and cynomolgus monkeys. Mech Ageing Dev 51 1990 101 120
70. CB Toris ME Yablonski CB Camras RF Brubaker Mechanism of the ocular hypotensive effect oflatanoprost and the maintenance of normal blood-aqueous barrier function Surv Ophthalmol 41 Suppl 2 1997 S69 S75
71. WG Unger Mediation of the ocular response to injury and irritation: Peptides versus prostaglandins Prog Clin Biol Res 312 1989 293 328
72. P Wistrand J Stjernschantz K Ohlsson The incidence and time-course of latanoprost-induced iridial pigmentation, as a tunction of eye colol Surv Ophthahnol 41 Suppl 2 1997 S129 S138
73. B Winn B Gilmartin Current perspective on microfluctuations of accommodation Ophthalm Physiol Opt 12 1992 252 256
74. DE Woodward JW Regan S Lake A Ocklind The molecular biology and ocular distribution ofprostanoid receptors Surv Ophthalmol 41 Suppl 2 1997 S15 S21
75. LS Woodward DE Williams J Chen Marked differential effects of prostanoid metabolites on rabbit intraocular pressure Ophthalmic Res 21 1989 428 435
76. T Yamamoto Y Kitazawa I Azuma K Masuda Phase 3 studies with Uf-021 (unoprostone) and clinical experience with Rescula Surv Ophthalmol 41 Suppl 2 1997 S99 S103